Forte Biosciences (FBRX) Interest Coverage Ratio (2016 - 2026)
Forte Biosciences' (FBRX) quarterly Interest Coverage Ratio came in at 0.51 in Q1 2026, up 97.38% year-on-year from 0.26 in Q1 2025, and up 99.91% on a QoQ basis from 571.42 in Q4 2025.
Forte Biosciences (FBRX) Interest Coverage Ratio (2016 - 2026) Analysis & Trends
Forte Biosciences (FBRX) has 11 years of Interest Coverage Ratio data on file, last reported at 0.51 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 97.38% year-over-year to 0.51 in Q1 2026; TTM through Mar 2026 was 1.76, a 96.77% increase from a year earlier, with the FY2025 full-year figure at 1.5, changed 0.48% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.51, up from 571.42 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for FBRX reached as high as 0.51 in Q1 2026 and fell as low as 2043.2 in Q3 2023.
- Historically, Interest Coverage Ratio has averaged 253.17 across 5 years, with a median of 90.75 in 2024.
- Across the five-year window, Interest Coverage Ratio slumped 21979.07% in 2022 and surged 99.8% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 75.98 in 2022, then sank by 179.93% to 212.7 in 2023, then surged by 57.33% to 90.75 in 2024, then plunged by 529.64% to 571.42 in 2025, then soared by 99.91% to 0.51 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.51 in Q1 2026, 571.42 in Q4 2025, and 1.06 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Forte Biosciences | 174.08 Mn | 115.88 Mn | - | -0.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.51 |
| Dec 31, 2025 | -571.42 |
| Sep 30, 2025 | -1.06 |
| Jun 30, 2025 | -0.89 |
| Mar 31, 2025 | -19.62 |
| Dec 31, 2024 | -90.75 |
| Sep 30, 2024 | -308.18 |
| Jun 30, 2024 | -442.00 |
| Mar 31, 2024 | -278.71 |
| Dec 31, 2023 | -212.70 |
| Sep 30, 2023 | -2,043.20 |
| Jun 30, 2023 | -103.84 |
| Mar 31, 2023 | -97.93 |
| Dec 31, 2022 | -75.98 |
| Sep 30, 2022 | -34.93 |
| Jun 30, 2022 | -13.85 |
| Mar 31, 2022 | -8.27 |
| Dec 31, 2021 | -0.34 |
| Sep 30, 2021 | -7.43 |
| Jun 30, 2021 | -0.25 |